Industry highlights: Stem cell and regenerative medicine.
作者信息
Ilic Dusko
机构信息
Human Embryonic Stem Cell Laboratories, Guy's Assisted Conception Unit, Division of Women's Health, King's College London School of Medicine.
出版信息
Regen Med. 2011 Nov;6(6 Suppl):55-60. doi: 10.2217/rme.11.55.
PMID:21999262
Abstract
摘要
相似文献
1
Industry highlights: Stem cell and regenerative medicine.行业亮点：干细胞与再生医学。
Regen Med. 2011 Nov;6(6 Suppl):55-60. doi: 10.2217/rme.11.55.
2
Conditional approval: Japan lowers the bar for regenerative medicine products.有条件批准：日本降低再生医学产品标准。
Cell Stem Cell. 2015 Apr 2;16(4):353-6. doi: 10.1016/j.stem.2015.03.013.
3
The need for a regen industry voice.再生行业发声的必要性。
Regen Med. 2008 Sep;3(5):621-31. doi: 10.2217/17460751.3.5.621.
4
The UK relative to other single payer-dominated healthcare markets for regenerative medicine therapies.英国相对于其他以单一支付者为主导的再生医学治疗市场。
Regen Med. 2012 May;7(3):429-38. doi: 10.2217/rme.11.125.
5
Regenerative medicine and the developing world.再生医学与发展中世界
PLoS Med. 2006 Sep;3(9):e381. doi: 10.1371/journal.pmed.0030381.
6
The deadly business of an unregulated global stem cell industry.无监管的全球干细胞产业的致命生意。
J Med Ethics. 2017 Nov;43(11):744-746. doi: 10.1136/medethics-2016-104046. Epub 2017 Mar 29.
7
FDA's claims over stem cells upheld.美国食品药品监督管理局对干细胞的声明得到支持。
Nature. 2012 Aug 2;488(7409):14. doi: 10.1038/488014a.
8
Welcome to the World Stem Cell Report.欢迎阅读《世界干细胞报告》。
Regen Med. 2011 Nov;6(6 Suppl):1-2. doi: 10.2217/rme.11.87.
9
Study: Business Booms for Unlicensed and Unproven Stem Cell Treatments.研究：未经许可和未经证实的干细胞治疗业务蓬勃发展。
JAMA. 2022 Feb 1;327(5):414-415. doi: 10.1001/jama.2021.22793.
10
Advances in stem cells technologies and their commercialization potential.干细胞技术的进展及其商业化潜力。
Expert Rev Clin Pharmacol. 2013 Jul;6(4):363-5. doi: 10.1586/17512433.2013.811804.
引用本文的文献
1
Mesenchymal stem cells in regenerative rehabilitation.再生康复中的间充质干细胞
J Phys Ther Sci. 2016 Jun;28(6):1943-8. doi: 10.1589/jpts.28.1943. Epub 2016 Jun 28.
Zotero 插件